v3.26.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 410.0 $ 591.9
Accounts receivable, less allowance for credit losses 1,769.5 1,704.4
Inventories 2,270.3 2,286.4
Prepaid expenses and other current assets 646.9 537.3
Total Current Assets 5,096.7 5,119.9
Property, plant and equipment, net 2,236.8 2,207.1
Goodwill 9,919.5 9,947.1
Intangible assets, net 4,461.6 4,717.3
Other assets 1,083.3 1,100.3
Total Assets 22,797.8 23,091.7
Current Liabilities:    
Accounts payable 352.4 303.0
Salaries, wages and benefits 334.3 477.1
Other current liabilities 1,125.3 1,216.5
Current portion of long-term debt 1,201.5 587.1
Total Current Liabilities 3,013.5 2,583.7
Deferred income taxes, net 235.6 244.1
Other long-term liabilities 638.7 626.1
Long-term debt 6,277.5 6,932.0
Total Liabilities 10,165.3 10,386.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 319.4 million shares as of June 30, 2026 (318.7 million as of December 31, 2025) issued 3.2 3.2
Paid-in capital 10,223.2 10,178.6
Retained earnings 11,955.1 11,611.0
Accumulated other comprehensive loss (163.9) (205.7)
Treasury stock, 128.8 million shares as of June 30, 2026 (123.2 million as of December 31, 2025) (9,393.7) (8,889.4)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 12,623.9 12,697.7
Noncontrolling interest 8.7 8.1
Total Stockholders' Equity 12,632.5 12,705.8
Total Liabilities and Stockholders' Equity $ 22,797.8 $ 23,091.7